Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
870.4 USD | +2.40% |
|
+3.72% | +47.91% |
09:19pm | FDA advisory panel votes in favor of data for Lilly Alzheimer's drug | RE |
01:00pm | US FDA advisers to review Eli Lilly Alzheimer's drug | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+47.91% | 765B | |
-6.15% | 354B | |
+20.55% | 331B | |
+9.77% | 299B | |
+18.87% | 248B | |
-1.96% | 219B | |
+11.11% | 216B | |
+5.33% | 164B | |
-2.48% | 162B | |
+0.57% | 123B |
- Stock Market
- Equities
- LLY Stock
- News Eli Lilly and Company
- Redburn Atlantic Adjusts Eli Lilly Price Target to $600 From $540